Business & Industry
CMS Extends GENEROUS MFN Drug Pricing Deadline to April
The Centers for Medicare & Medicaid Services (CMS) in the US has moved to extend the enrolment window for its GENEROUS pilot programme, an...
Business & Industry
Lilly Launches New AI Supercomputer for Drug Development
Eli Lilly has launched what it describes as the most powerful AI factory wholly owned and operated by a pharmaceutical company, marking a significant...
News
Periodontal Disease as a Modifiable Risk Factor in Systemic Conditions
Periodontal disease has long been viewed primarily as a localized oral condition affecting the supporting structures of the teeth.
However, growing evidence suggests that its...
News
How Pharma is Navigating EPR’s Split-Tier Reality in 2026 without Losing Regulatory Sterility
In 2026, the Pharmaceutical and Medical Device sectors face a "split-tier" EPR reality. Unlike general consumer goods, pharma has specific exemptions and unique traps...
Business & Industry
Ensuring Regulatory Compliance in Pharmaceutical QC Labs
Ensuring regulatory compliance in pharmaceutical Quality Control labs requires advanced analytical capabilities, robust data integrity systems, and strict adherence to evolving global GMP standards. By integrating lifecycle-based method validation, digital traceability, and ultra-trace impurity detection, QC laboratories safeguard product quality and patient safety at every stage of manufacturing.
Business & Industry
Novo Nordisk and Vivtex Sign Strategic Oral Biologics Deal
Novo Nordisk and Vivtex have formalised a collaboration aimed at advancing next-generation oral biologic therapies targeting obesity, diabetes and related comorbidities.
Under the terms of...
Business & Industry
Integrated Health Risk Assessment in Food and Pharma Sectors
Integrated health risk assessment in food and pharma sectors aligns toxicology, exposure modeling, and regulatory standards to address cumulative chemical risks across daily consumption and therapy. By harmonizing methodologies and leveraging shared data, regulators and manufacturers can build a more holistic, science-driven safety framework that protects long-term public health.
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read















